3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 1 0 0 0 0 0999 V2000
3.4515 -0.6404 0.2032 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7341 1.6305 0.3362 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6344 0.6656 0.0635 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1119 -0.6636 0.1078 C 0 0 1 0 0 0 0 0 0 0 0 0
-0.0056 -0.9025 -0.8882 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3512 -1.4935 -0.1572 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3263 -0.3688 -0.4158 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0045 0.6575 0.2077 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1727 -1.1850 0.3261 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6911 0.9368 -0.7241 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4002 -0.6891 0.7653 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9186 1.4328 -0.2847 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7731 0.6197 0.4601 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7752 -0.8338 1.1384 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.1152 -1.9807 -1.0673 H 0 0 0 0 0 0 0 0 0 0 0 0
0.2403 -0.4681 -1.8666 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3759 -2.4026 0.4510 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4705 -1.7684 -1.2109 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0724 1.5099 0.1092 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8918 -2.2053 0.5722 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.0353 1.5792 -1.3053 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.0653 -1.3218 1.3457 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.2093 2.4518 -0.5227 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.7287 1.0060 0.8022 H 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0 0 0 0
1 8 1 0 0 0 0
2 8 2 0 0 0 0
3 4 1 0 0 0 0
3 8 1 0 0 0 0
3 19 1 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 14 1 0 0 0 0
5 7 1 0 0 0 0
5 15 1 0 0 0 0
5 16 1 0 0 0 0
6 17 1 0 0 0 0
6 18 1 0 0 0 0
7 9 2 0 0 0 0
7 10 1 0 0 0 0
9 11 1 0 0 0 0
9 20 1 0 0 0 0
10 12 2 0 0 0 0
10 21 1 0 0 0 0
11 13 2 0 0 0 0
11 22 1 0 0 0 0
12 13 1 0 0 0 0
12 23 1 0 0 0 0
13 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(4S)-4-benzyl-1,3-oxazolidin-2-one
4.2 InChl
InChI=1S/C10H11NO2/c12-10-11-9(7-13-10)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,11,12)/t9-/m0/s1
4.3 InChlKey
OJOFMLDBXPDXLQ-VIFPVBQESA-N
4.4 Canonical SMILES
C1C(NC(=O)O1)CC2=CC=CC=C2
4.5 lsomeric SMILES
C1[C@@H](NC(=O)O1)CC2=CC=CC=C2
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病